Huadong Medicine's (SHE:000963) unit, Hangzhou Sino-US Huadong Pharmaceutical, has received a medical device registration certificate from China's drug administration for its Transcutaneous Glomerular Filtration Rate Measurement Device.
The newly approved device consists of a host unit, a sensor, and a fixing sticker, and is designed for non-invasive measurement of glomerular filtration rate (GFR). GFR is a key indicator of kidney function.
The company's shares rose more than 1% in recent trade.